CTT Pharmaceutical Holdings, Inc.
CTTH
$0.08
-$0.01-6.25%
OTC PK
| 03/31/2026 | 03/31/2025 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Net Income | -68.39% | 37.10% | -7.59% | 46.36% | -1,429.20% |
| Total Depreciation and Amortization | 6.25% | -75.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 157.51% | -- | 6.31% | -53.20% | 5,461.47% |
| Change in Net Operating Assets | -61.39% | -145.12% | 132.85% | 155.92% | -508.33% |
| Cash from Operations | -24.84% | 86.16% | 26.45% | 15.17% | -93.39% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -- | -- | -90.21% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -88.60% | -64.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10,900.00% | -64.94% | -90.21% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -129.41% | 25.93% | 325.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.39% | 48,300.00% | -255.84% | 82.54% | -136.27% |